Navigation Links
BellBrook Labs and Tecan Offer Webinar on Screening Epigenetic Targets
Date:7/14/2013

Madison, WI (PRWEB) July 14, 2013

Join us for a webinar on July 17, 2013 at 12:00 PM EDT:

Tools for Screening Chromatin Modifying Enzymes

Register now: https://attendee.gotowebinar.com/register/503711917036579328

Biochemical HTS assays are a critical component of drug discovery programs focused on epigenetic drug targets like methyltransferases, acetyltransferases or kinases. Assembling high quality assay reagents and validating them on a detection platform that can deliver speed, accuracy and reproducibility can consume a significant amount of time and resources. The shift toward screening focused libraries against multiple targets in parallel can add to the assay development burden substantially.

In this webinar you will learn:

  • How a few different Transcreener HTS Assays allow robust, initial velocity detection of hundreds of chromatin modifying enzymes, including methyltransferases, acetyltransferases, kinases, glycosyltransferases, and SUMO ligases.
  • How to sync Transcreener assays with Tecan’s plate readers to generate high quality screening or profiling data.
  • How to eliminate costly biochemical assay development using turnkey kits combining Transcreener assays and pre-calibrated kinase and methyltransferase enzymes and substrates.

Participants should come away confident that they can apply a robust, cost-effective, user friendly solution to immediately begin screening or profiling chromatin modifying enzymes.

After registering, you will receive a confirmation email containing information about joining the webinar.

About BellBrook Labs. BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions for enzymes and phenotypic assays. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. The iuvo™ Microconduit Array technology and assay screening service is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.

About Tecan. Tecan (http://www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10924304.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
2. BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases
3. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
4. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
5. Poliwogg’s Greg Simon Says Lifting of SEC Solicitation Ban for Private Offerings Will Vastly Expand Healthcare Investment
6. Vetter Offers a Sterile Water-for-injection Solution with 5 Years Stability Data
7. Cellular Dynamics International Announces Launch of Initial Public Offering
8. Intrexon Announces Filing of Registration Statement For Proposed Initial Public Offering
9. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
10. Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
11. St. Josephs Hospital is the First in Florida to Offer Non-invasive Test to Predict Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... DIEGO , Feb. 22, 2017  Creative ... expansion of its translational research program using its ... of laboratory facilities in San Diego.  The Company ... BioLabs facility, a biotechnology incubator sponsored by the ... In November 2016, the Company obtained an ...
(Date:2/21/2017)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... months ended December 31, 2016. SQI is ... company that develops and commercializes proprietary technologies and products for ... ... milestones achieved in fiscal 2016," said Andrew Morris , ...
(Date:2/21/2017)... Switzerland (PRWEB) , ... February 21, 2017 , ... ... biopharmaceutical and biotech research and development (R&D), today announced the establishment of Genedata ... by Managing Director Kevin Teburi, a recognized expert in life science informatics. Creating ...
(Date:2/21/2017)... Chicago, IL (PRWEB) , ... ... ... launch of the Life -Sciences division, Treximo will pair its $200M operational ... class, results-based consulting and project management in areas affecting quality and operational ...
Breaking Biology Technology:
(Date:2/9/2017)... , Feb. 9, 2017 The biomass ... analysis of the biomass boiler market globally in terms ... of biomass boilers. The market for biomass boilers has ... type, end-user, application, and country/region. The market based on ... & forest residues, biogas & energy crops, urban residues, ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
Breaking Biology News(10 mins):